August 16, 2018
Rose
The moves add to a picture of growing investor unease over the health of large biotech companies, which are being pushed to find successors for aging blockbuster drugs. In other pharmaceutical news: Pfizer is investing in a better flu vaccine, a startup struggles to build interest by male doctors for a drug that benefits women; and a deeper look at CAR-T therapy.
from Kaiser Health News https://ift.tt/2nJK3R2
August 16, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
‘Vaginal Rejuvenation’ Treatments Are Dangerous And Deceptive, FDA Warns- Watchdog Agency Calls On Regulators To Ramp Up Oversight Of Hospice Industry After Report On Fraud, Neglect
- Without Opioids For Back Pain, Patients Explore Dangerous Treatment Banned In Other Countries
- States Sue Trump Administration Over 3D-Printed Guns That Are Unregistered, Difficult To Catch With Metal Detectors
- Does The ‘Medicare-For-All’ Price Tag Seem Staggering? Some Experts Say It Goes Beyond Just The Basic Numbers
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment